Juan Graham sold $85k of KYNB
Chief Financial Officer at FIBROGEN INC. 5,741 shares at an average of $14.89, traded Dec 8, 2022, filed Dec 15, 2022.
Score components
- +22RoleCFO
- +9Trade size$85k at market
- +5Share of holdings soldSold 10% of holdings
- +15Cluster4 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001209191-22-061483, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 8, 2022 | SOpen-market sale Common Stock10b5-1 | -5,263 | $14.84 | $78k | 50,628 | Dec 15, 2022 |
| Dec 8, 2022 | SOpen-market sale Common Stock10b5-1 | -478 | $15.47 | $7,395 | 50,150 | Dec 15, 2022 |
Related signals
Other insiders at FIBROGEN INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 36Weak | KYNBbuy FIBROGEN INC | Thane Wettig CEO | $20k 2,800 shares | +11% | |
| 36Weak | KYNBbuy FIBROGEN INC | Thane Wettig CEO | $20k 2,800 shares | +11% | |
| 42Moderate | KYNBbuy FIBROGEN INC | Thane Wettig CEO | $34k 3,700 shares | +17% | |
| 53Moderate | KYNBbuy FIBROGEN INC | James A Schoeneck director | $119k 23,567 shares | +146% | |
| 46Moderate | FIBROGEN INC | Thane Wettig CEO | $51k 145,000 shares | +36% | |
| 43Moderate | FIBROGEN INC | James A Schoeneck director | $105k 300,000 shares | +407% | |
| 34Weak | KYNBbuy FIBROGEN INC | Deyaa Adib Chief Medical Officer | $26k 22,123 shares | +37% | |
| 46Moderate | KYNBbuy FIBROGEN INC | Thane Wettig CEO | $95k 50,000 shares | +12% | |
| 38Weak | FIBROGEN INC | Christine Chung SVP, China Operations | $330k 15,960 shares | -6% | |
| 63Notable | FIBROGEN INC | Enrique A Conterno Chief Executive Officer | $1.2M 56,261 shares | -15% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.